Wegovy (Semaglutide) Weight Loss Injection Pens – 4-Week Pack

Wegovy® (semaglutide) Injection | Comprehensive Product Overview

Wegovy® is a prescription injectable medicine manufactured by Novo Nordisk, engineered to support long-term weight management in adults with:

• Obesity (BMI ≥ 30 kg/m²), or
• Overweight (BMI ≥ 27 kg/m²) accompanied by at least one weight-related comorbid condition (e.g., hypertension, type 2 diabetes mellitus, or dyslipidemia).

It is also indicated to reduce the risk of major adverse cardiovascular events (such as cardiovascular death, heart attack, or stroke) in adults with established cardiovascular disease and obesity or overweight.

How Wegovy® Works

The active ingredient, semaglutide, is a glucagon-like peptide-1 (GLP-1) receptor agonist that targets brain receptors regulating appetite and food intake:

• Prolongs Fullness: Slows gastric emptying to extend feelings of satiety after meals.
• Controls Appetite: Targets hunger centers in the brain to reduce cravings and overall caloric intake.
• Supports Metabolic Health: Aids in glycemic regulation and cardiovascular risk reduction.

Dosage & Titration Schedule

Wegovy is administered once weekly on the same day each week, with or without food. To improve gastrointestinal tolerance, treatment follows a standard 5-step monthly dose escalation schedule:

• Month 1 (Weeks 1–4): 0.25 mg weekly (Initiation)
• Month 2 (Weeks 5–8): 0.5 mg weekly (Escalation)
• Month 3 (Weeks 9–12): 1.0 mg weekly (Escalation)
• Month 4 (Weeks 13–16): 1.7 mg weekly (Escalation / Maintenance)
• Month 5+ (Week 17 onward): 2.4 mg weekly (Target Maintenance Dose)

Key Product Features

• Pre-Filled Auto-Injector Pens: Pre-set single-dose pens with an integrated, hidden needle.
• Weekly Convenience: Only requires one subcutaneous injection per week (abdomen, thigh, or upper arm).
• Clinically Proven: Demonstrated significant average body weight reduction in clinical trials when paired with lifestyle interventions.

Storage & Handling

• Store refrigerated at 2°C to 8°C (36°F to 46°F) in original carton to protect from light.
• Do not freeze.
• Can be kept at room temperature (up to 30°C / 86°F) for up to 28 days before the cap is removed.

Important Safety Information

• Prescription Only (Rx): Requires valid medical prescription or approved clinical consultation.
• Contraindications: Personal or family history of Medullary Thyroid Carcinoma (MTC), Multiple Endocrine Neoplasia syndrome type 2 (MEN 2), or serious allergy to semaglutide.
• Common Side Effects: Nausea, diarrhea, vomiting, constipation, abdominal discomfort, headache, and fatigue.